Colgate-Palmolive Company (CL)vs22nd Century Group Inc (XXII)
CL
Colgate-Palmolive Company
$85.36
+1.03%
CONSUMER DEFENSIVE · Cap: $67.91B
XXII
22nd Century Group Inc
$1.56
-3.11%
CONSUMER DEFENSIVE · Cap: $1.20M
Smart Verdict
WallStSmart Research — data-driven comparison
Colgate-Palmolive Company generates 289047% more annual revenue ($20.38B vs $7.05M). CL leads profitability with a 10.5% profit margin vs -71.7%. CL earns a higher WallStSmart Score of 62/100 (C+).
CL
Buy62
out of 100
Grade: C+
XXII
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+17.8%
Fair Value
$102.75
Current Price
$85.36
$17.39 discount
Margin of Safety
+70.6%
Fair Value
$19.09
Current Price
$1.56
$17.53 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 50 in profit
Large-cap with strong market position
Strong operational efficiency at 20.4%
Generating 1.3B in free cash flow
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
1.1% earnings growth
Weak financial health signals
Trading at 1219.4x book value
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -116.6% — below average capital efficiency
Revenue declined 43.1%
Comparative Analysis Report
WallStSmart ResearchBull Case : CL
The strongest argument for CL centers on Return on Equity, Market Cap, Operating Margin.
Bull Case : XXII
The strongest argument for XXII centers on Price/Book.
Bear Case : CL
The primary concerns for CL are P/E Ratio, EPS Growth, Piotroski F-Score. Debt-to-equity of 147.93 is elevated, increasing financial risk.
Bear Case : XXII
The primary concerns for XXII are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
CL profiles as a value stock while XXII is a turnaround play — different risk/reward profiles.
XXII carries more volatility with a beta of 1.12 — expect wider price swings.
CL is growing revenue faster at 5.8% — sustainability is the question.
CL generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
CL scores higher overall (62/100 vs 31/100). XXII offers better value entry with a 70.6% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Colgate-Palmolive Company
CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA
Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.
Visit Website →22nd Century Group Inc
CONSUMER DEFENSIVE · TOBACCO · USA
22nd Century Group Inc (Ticker: XXII) is an innovative biopharmaceutical and agricultural company dedicated to tobacco harm reduction through advanced genetic engineering techniques. By focusing on the development of low-nicotine tobacco products, the firm aims to mitigate nicotine addiction while enhancing public health outcomes. As it strategically diversifies into the burgeoning hemp and cannabis markets, 22nd Century positions itself to capitalize on the expanding legal cannabis landscape. With a robust commitment to scientific research and adherence to regulatory frameworks, the company represents a compelling investment opportunity for institutional investors looking to engage in transformative sectors.
Compare with Other HOUSEHOLD & PERSONAL PRODUCTS Stocks
Want to dig deeper into these stocks?